← FDA DRUG APPROVALS

FDA ANDA · ANDA089029

PROCAINAMIDE HYDROCHLORIDE

Sponsor: HIKMA

APPLICATION
ANDA089029
TYPE
ANDA
ORIGINAL APPROVAL
1986-04-17
LATEST ACTION
2000-04-03
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PROCAINAMIDE HYDROCHLORIDEDiscontinued
PROCAINAMIDE HYDROCHLORIDE 100MG/ML · INJECTABLE · INJECTION

Approval history

2000-04-03Manufacturing (CMC) · Supplement 9AP
1998-06-12Labeling · Supplement 8AP
1991-12-09Labeling · Supplement 6AP
1988-11-07Labeling · Supplement 5AP
1988-03-04Manufacturing (CMC) · Supplement 4AP
1986-11-03Manufacturing (CMC) · Supplement 2AP
1986-09-05Manufacturing (CMC) · Supplement 1AP
1986-04-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →